Literature DB >> 22956036

[Dermatological conditions requiring intensive care].

C Marks1, R Marks.   

Abstract

Some skin conditions may require treatment in intensive care units. The early diagnosis of life-threatening dermatoses is a considerable challenge. We review skin diseases which may require intensive care. In addition to Stevens-Johnson syndrome and toxic epidermal necrolysis, representing adverse skin reactions, we discuss staphylococcal scalded skin syndrome and necrotizing fasciitis as infection-associated dermatoses, as well as angioedema. We focus on the course of disease describing clinical presentations, diagnostics and therapeutic strategies with respect to critical medical conditions.

Entities:  

Mesh:

Year:  2012        PMID: 22956036     DOI: 10.1007/s00105-012-2421-0

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  36 in total

1.  Epidemiology of staphylococcal scalded skin syndrome in Germany.

Authors:  Maja Mockenhaupt; Marco Idzko; Martine Grosber; Erwin Schöpf; Johannes Norgauer
Journal:  J Invest Dermatol       Date:  2005-04       Impact factor: 8.551

Review 2.  Pediatric dermatology emergencies.

Authors:  Douglas W Kress
Journal:  Curr Opin Pediatr       Date:  2011-08       Impact factor: 2.856

3.  Nevirapine and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis.

Authors:  J P Fagot; M Mockenhaupt; J N Bouwes-Bavinck; L Naldi; C Viboud; J C Roujeau
Journal:  AIDS       Date:  2001-09-28       Impact factor: 4.177

Review 4.  Necrotizing fasciitis: classification, diagnosis, and management.

Authors:  Luca Lancerotto; Ilaria Tocco; Roberto Salmaso; Vincenzo Vindigni; Franco Bassetto
Journal:  J Trauma Acute Care Surg       Date:  2012-03       Impact factor: 3.313

Review 5.  Treatment of severe drug reactions: Stevens-Johnson syndrome, toxic epidermal necrolysis and hypersensitivity syndrome.

Authors:  Pierre-Dominique Ghislain; Jean-Claude Roujeau
Journal:  Dermatol Online J       Date:  2002-06

6.  Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study.

Authors:  Ariane Auquier-Dunant; Maja Mockenhaupt; Luigi Naldi; Osvaldo Correia; Werner Schröder; Jean-Claude Roujeau
Journal:  Arch Dermatol       Date:  2002-08

Review 7.  Linezolid versus vancomycin for the treatment of gram-positive bacterial infections: meta-analysis of randomised controlled trials.

Authors:  Liang Beibei; Cai Yun; Chen Mengli; Bai Nan; Yu Xuhong; Wang Rui
Journal:  Int J Antimicrob Agents       Date:  2009-11-08       Impact factor: 5.283

8.  Randomised comparison of thalidomide versus placebo in toxic epidermal necrolysis.

Authors:  P Wolkenstein; J Latarjet; J C Roujeau; C Duguet; S Boudeau; L Vaillant; M Maignan; M H Schuhmacher; B Milpied; A Pilorget; H Bocquet; C Brun-Buisson; J Revuz
Journal:  Lancet       Date:  1998-11-14       Impact factor: 79.321

9.  Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel.

Authors:  Sima Halevy; Pierre-Dominique Ghislain; Maja Mockenhaupt; Jean-Paul Fagot; Jan Nico Bouwes Bavinck; Alexis Sidoroff; Luigi Naldi; Ariane Dunant; Cecile Viboud; Jean-Claude Roujeau
Journal:  J Am Acad Dermatol       Date:  2007-10-24       Impact factor: 11.527

10.  Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin.

Authors:  I Viard; P Wehrli; R Bullani; P Schneider; N Holler; D Salomon; T Hunziker; J H Saurat; J Tschopp; L E French
Journal:  Science       Date:  1998-10-16       Impact factor: 47.728

View more
  1 in total

1.  Improvement of a Clinical Score for Necrotizing Fasciitis: 'Pain Out of Proportion' and High CRP Levels Aid the Diagnosis.

Authors:  Thomas Borschitz; Svenja Schlicht; Ekkehard Siegel; Eric Hanke; Esther von Stebut
Journal:  PLoS One       Date:  2015-07-21       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.